Skip to main content

Table 1 Critical appraisal for methodological quality

From: Effectiveness and safety of the combination of sodium–glucose transport protein 2 inhibitors and glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes mellitus: a systematic review and meta-analysis of observational studies

Author name and year

Were the two groups similar and recruited from the same population?

Were the exposures measured similarly to assign people to both exposed and unexposed groups?

Was the exposure measured in a valid and reliable way?

Were confounding factors identified?

Were strategies to deal with confounding factors stated?

Were the groups/participants free of the outcome at the start of the study (or at the moment of exposure)?

Were the outcomes measured in a valid and reliable way?

Was the follow-up time reported and sufficient to be long enough for outcomes to occur?

Was follow-up complete, and if not, were the reasons for loss to follow-up described and explored?

Were strategies to address incomplete follow-up utilized?

Was appropriate statistical analysis used?

Score

Berkovic et al. 2020

N/A

N/A

9

Gorgojo-Martínez et al. 2017

?

N/A

N/A

7

Kim et al. 2022

N/A

N/A

9

Deol et al. 2017

N/A

N/A

9

Carretero-Gómez et al. 2019

N/A

N/A

?

8

Arevalo et al. 2018

?

N/A

N/A

?

5

Diaz et al. 2020

N/A

?

?

N/A

?

6

Carretero-Gómez et al. 2020

?

?

N/A

N/A

7

Riley et al. 2023

?

N/A

N/A

?

5

Goncalves et al. 2017

?

N/A

?

N/A

5

Bhattacharyya et al. 2020

N/A

N/A

7

Saroka et al. 2015

?

N/A

8

Jensen et al. 2020

?

N/A

N/A

7

  1. : Yes; ✗: No; ?: Unclear; N/A: Not applicable